Characteristics of Transgender Women Living with HIV Receiving Medical Care in the United States

LGBT Health
Yuko MizunoJacek Skarbinski

Abstract

Little has been reported from population-based surveys on the characteristics of transgender persons living with HIV. Using Medical Monitoring Project (MMP) data, we describe the characteristics of HIV-infected transgender women and examine their care and treatment needs. We used combined data from the 2009 to 2011 cycles of MMP, an HIV surveillance system designed to produce nationally representative estimates of the characteristics of HIV-infected adults receiving medical care in the United States, to compare demographic, behavioral, and clinical characteristics, and met and unmet needs for supportive services of transgender women with those of non-transgender persons using Rao-Scott chi-square tests. An estimated 1.3% of HIV-infected persons receiving care in the United States self-identified as transgender women. Transgender women were socioeconomically more marginalized than non-transgender men and women. We found no differences between transgender women and non-transgender men and women in the percentages prescribed antiretroviral therapy (ART). However, a significantly lower percentage of transgender women compared to non-transgender men had 100% ART dose adherence (78.4% vs. 87.4%) and durable viral suppression (50.8% v...Continue Reading

References

Aug 19, 2007·AIDS and Behavior·Jeffrey H HerbstUNKNOWN HIV/AIDS Prevention Research Synthesis Team
Mar 30, 2010·The Journal of the Association of Nurses in AIDS Care : JANAC·Jae M SeveliusMallory O Johnson
Nov 30, 2011·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Jae M SeveliusLuis Gutierrez-Mock
Dec 25, 2012·The Lancet Infectious Diseases·Stefan D BaralChris Beyrer
Jun 1, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Baligh R YehiaKelly A Gebo
Dec 10, 2013·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Jae M SeveliusMallory O Johnson

❮ Previous
Next ❯

Citations

Feb 26, 2016·AIDS Care·Glenda N BagusoKathryn A Lee
Jul 20, 2018·AIDS Care·Jennifer D UhrigNickolas DeLuca
Aug 26, 2017·The Journal of the Association of Nurses in AIDS Care : JANAC·Lauren MunroRobb Travers
May 1, 2019·Journal of the International AIDS Society·Glenda N BagusoErin C Wilson
Nov 17, 2019·International Journal of Environmental Research and Public Health·Theo BeltranErin C Wilson
Jan 17, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Akarin HiransuthikulNittaya Phanuphak
Jul 17, 2020·American Journal of Public Health·Sarah M PeitzmeierSari L Reisner
Apr 26, 2017·Journal of the International AIDS Society
Jul 2, 2019·AIDS Patient Care and STDs·Ashley Lacombe-DuncanMona Loutfy
Oct 2, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Tonia PoteatKeri N Althoff
Apr 30, 2019·The Nurse Practitioner·Denise RoweLouise C OʼKeefe
Feb 23, 2021·Lancet·Adaora A AdimoraMonica Gandhi
May 7, 2021·International Journal of Behavioral Medicine·Pablo D RaduskyOmar Sued
May 19, 2021·AIDS and Behavior·Jessica Xavier
Jul 27, 2021·Open Forum Infectious Diseases·Timothy W MenzaLinda Drach

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.